A 90-year-old Skier on Living an Active Life With an Alzheimer’s Diagnosis
This article is part of the Journey to Diagnosis series, produced by Being Patient with support provided by Eli Lilly. In the newest definition…
This article is part of the Journey to Diagnosis series, produced by Being Patient with support provided by Eli Lilly. In the newest definition…
The holidays bring joy, togetherness, and a healthy dose of chaos—a mix that can be challenging for anyone, let alone individuals living with dementia…
An international group of researchers is challenging the controversial new definition of Alzheimer’s proposed by a group of researchers convened by the Alzheimer’s Association….
People tend to look at Alzheimer’s disease progression in a framework of seven stages. In the final stage, people with the disease often lose…
A recent Science investigation found that Eliezer Masliah, one of the world’s leading Alzheimer’s and Parkinson’s researchers, engaged in research misconduct over the course…
Hardly a week goes by when I don’t receive an email or a call from a friend whose parent has just gotten an Alzheimer’s…
Before 1993, researchers seldom included women in clinical trials. And yet, women have dramatically different risk of health conditions than men do. For example,…
Precision medicine is a medical approach that considers a patient’s genes, environment, and lifestyle. In the realm of Alzheimer’s disease, experts are pushing for…
There are plenty of gifts designed specifically for people living with dementia that can be helpful, calming or stress-relieving, whether they’re intended to spur…
The holidays are often a joyous time filled with celebrations, and experts say tailoring activities to the changing abilities of family members living with…
Mild cognitive impairment affects millions of people worldwide, and it often goes undiagnosed and untreated — even though it can sometimes be treatable and…
For decades, scientists blamed Alzheimer’s disease on the buildup of beta-amyloid protein plaques in the brain. But most clinical trials for drugs intended to…
On November 25th, Cassava Sciences announced their experimental Alzheimer’s drug simufilam failed to slow cognitive or functional decline in its 52-week Phase 3 trial….
This article is part of the Journey to Diagnosis series, produced by Being Patient with support provided by Eli Lilly. Creativity can flourish for…
‘Tis the season when the conversation shifts to what you’re thankful for. Gathered with family and friends around a holiday feast, for instance, people…